Background Artificial intelligence methods in combination with the latest technologies,
including medical devices, mobile computing, and sensor technologies, have the potential to …

The remarkable advances in biotechnology and health sciences have led to a significant
production of data, such as high throughput genetic data and clinical information, generated …

The emergence and continued reliance on the Internet and related technologies has
resulted in the generation of large amounts of data that can be made available for analyses …

An estimated 425 million people globally have diabetes, accounting for 12% of the world's
health expenditures, and yet 1 in 2 persons remain undiagnosed and untreated …

Worldwide, the number of people affected by diabetes is rapidly increasing due to aging
populations and sedentary lifestyles, with the prospect of exceeding 500 million cases in …

Abstract Type 1 diabetes (T1D) is characterized by pancreatic beta cell dysfunction and
insulin depletion. Over 40% of people with T1D manage their glucose through multiple …

Wearable continuous glucose monitoring (CGM) sensors are revolutionizing the treatment of
type 1 diabetes (T1D). These sensors provide in real-time, every 1–5 min, the current blood …

The foreign body response impedes the function and longevity of implantable drug delivery
devices. As a dense fibrotic capsule forms, integration of the device with the host tissue …

Type 1 diabetes (T1D) is a chronic health condition resulting from pancreatic beta cell
dysfunction and insulin depletion. While automated insulin delivery systems are now …

(1) Background: People living with type 1 diabetes (T1D) require self-management to
maintain blood glucose (BG) levels in a therapeutic range through the delivery of exogenous …